PharmaNetra(TM) Enterprise
Nootan Pharmaceuticals · GMP Cloud
Connecting to server
Receive Packaging Material
Schedule M 2023 Cl.19 · Quarantine on receipt · CoA verification · AR mandatory
⚠ GMP Note: All PM received must be placed in Quarantine. QC must sample and release before use in production. PPM requires CoA + dimensional check. SPM requires artwork verification against approved proof.
⬆ Issue Material from Store
Schedule M 2023 · Requisition mandatory · FEFO · All issues audit-logged
--
⚠ GMP Note: Only Approved materials should be issued. Issue only against written requisition/BMR reference. Quantities will be deducted from stock immediately.
PharmaNetra™  v1.0  ·  GMP Compliant  ·  21 CFR Pt.11  ·  © 2024–2026 Dawabag Private Limited
Product Master -- Nootan Pharmaceuticals
🔒 FIXED PRODUCT IDENTITY -- NP Product Code Document R1 (17-03-26)
✎ VARIABLE FIELDS — Enter / Update as Required
held on the approved artwork of each pack
Asset Register -- Add / Edit
Expense Register -- Record Expense
Stock Entry -- Record Stock Transaction
Opening Stock · Received · Issued · Adjustment
Alt+C -- Create new item if not in list
Site Setup, Licences & GST Configuration
Manufacturing Site · Drug Licences · GST Registration · WHO/CDSCO · QP Details
Company / Manufacturing Site Details
GST Registration Details
Drug Licences & Regulatory Registrations
💊 Wholesale Drug Licence -- Form 20B (Allopathic Drugs)
💊 Wholesale Drug Licence -- Form 21B (Restricted Drugs)
🏭 Manufacturing Licence (Form 25 / 28)
🌐 CDSCO / WHO GMP Certificate
📦 Procurement Controls
Qualified Person & Authorised Signatories
Initiate New Production Batch
21 CFR 211.188 · Schedule M Cl.16 · E-Signature · Evidence Required
Batch Identification
Trade name is independent of the pharmacopoeial generic name below. Enter the marketed brand name here if applicable.
Generic Name & Active Pharmaceutical Ingredients (APIs) ⓘ Auto-filled from Product Master when product is selected above
🔒 Select from Product Master -- type to search by name / code / molecule / strength
Format: [INN Name] [Dosage Form] [Pharmacopoeia] [Strength] -- e.g. Cefixime Dispersible Tablet IP 50 mg
# API Code Pharmacopoeial API Name ★ Strength / Unit ★ CAS Number Pharmacopoeial Std (per API) Del
Single-API product: fill row 1 only. Combination product: add one row per API (e.g. Amoxicillin + Clavulanic Acid = 2 rows).
# Exc. Code Pharmacopoeial Excipient Name Function / Role Qty / Batch CAS Number Pharmacopoeial Std (per Excipient) Del
Add one row per excipient. Pharmacopoeial standard is set automatically from Excipient Master per excipient grade (IP or USP).
Manufacturing Setup
Dispensing, environmental conditions, equipment, line clearance and every signature for this batch are recorded on the server in the eBMR, signed where they are done. Nothing of them is entered here.
Add / Open Stock
Enter opening stock or receipt details -- all entries are audit-logged
📎 Evidence & Supporting Documents
Invoice / Delivery Challan ★
COA / Test Report
Other Supporting Documents
Receive Raw Material
Schedule M Cl.19 · WHO GMP · Quarantine on receipt · COA verification · Container-wise logging
Material Identification
Shipment & COA Details
Container-Wise Receipt Log ★ -- One row per container / drum / bag. Multiple supplier batches allowed.
# Supplier Batch No. ★ Container No. / Label Pack Size (kg/unit) Container Type Net Qty (kg/g/L) Tare (kg) Gross Wt. (kg) Seal Intact? Condition Remarks for this Container Del
Total containers: 0  |  Total quantity: 0
Receipt Sign-off
📎 Evidence & Raw Data Attachments
COA / Test Report (PDF) ★
📄

Attach PDF / Image

GRN / Delivery Challan
📄

Attach PDF / Image

Weighing / Sampling Record
📄

Attach PDF / Image

Record IPQC Test Result
In-Process Quality Control · Per BMR sampling plan
📎 Evidence & Raw Data Attachments
IPQC Data Sheet (PDF)
📄

Attach PDF / Image

Instrument Print / Chart
📄

Attach PDF / Image

Log New Deviation
ICH Q10 · FDA CAPA Guidance · WHO TRS 961 · Ishikawa / 5-Why
📎 Evidence & Raw Data Attachments
Deviation Report (Signed PDF)
📄

Attach PDF / Image

Root Cause Analysis Document
📄

Attach PDF / Image

CAPA Evidence / Photographs
📄

Attach PDF / Image

Log ICSR / Adverse Drug Reaction
ICH E2A/E2D · PvPI / CDSCO · WHO-UMC · de-identified patient data only
Case Administration
Patient (de-identified — DPDP Act 2023; NO name/address)
Suspect Product
Adverse Event & Assessment
Regulatory Reporting
📎 Attachments
ICSR / PvPI Form (PDF)
📄

Attach PDF / Image

Causality Assessment
📄

Attach PDF / Image

Supporting Documents
📄

Attach PDF / Image

Log New Incident
ICH Q10 · 21 CFR 211.192 · Quality Incident / Near-Miss
📎 Evidence & Attachments
Incident Report (PDF)
📄

Attach PDF / Image

Root Cause / Investigation
📄

Attach PDF / Image

Supporting Evidence / Photos
📄

Attach PDF / Image

Open OOS / OOT Report
21 CFR 211.192 · FDA OOS Guidance 2006 · Two-Phase Investigation
📎 Evidence & Raw Data Attachments
OOS Investigation Report (PDF)
📄

Attach PDF / Image

Lab Raw Data / Chromatogram
📄

Attach PDF / Image

Phase 2 Investigation Report
📄

Attach PDF / Image

Customer / Buyer Master
GST · Drug Licences · Bill-to & Ship-to · Credit Limit · Bank Details
Customer Identification
Statutory Registration & Tax Details
💊 Wholesale DL -- Form 20B
💊 Wholesale DL -- Form 21B
📄 Other Licences / Docs
Bill-To Address
Ship-To Address
Contact Details
Credit Limit & Payment Terms
🏦 Bank Details (for refunds / RTGS)
📄 Bank Documents
Add Vendor to Approved Vendor List (AVL)
ICH Q10 Risk-Based Qualification · Schedule M · WHO GMP · GST / PAN Required
Vendor Identification
Material / Product Name ★ Grade / Std. Category ★ UOM Lead Time Del
Statutory Registrations & Tax Details
GMP & Quality Certificates
Qualification & Audit
Drug Licences
💊 Wholesale DL -- Form 20B
💊 Wholesale DL -- Form 21B
Contact & Address
Payment Terms & Bank Details
Other Supporting Documents
Add Equipment
21 CFR 211.68 · Schedule M Cl.12 · IQ/OQ/PQ Required
📎 Evidence & Raw Data Attachments
Calibration Certificate (PDF) ★
📄

Attach PDF / Image

IQ / OQ / PQ Report
📄

Attach PDF / Image

PM Service Report
📄

Attach PDF / Image

Register SOP / Controlled Document
21 CFR 211.68 · Version Controlled · QP Approved
📎 Evidence & Raw Data Attachments
📎 SOP Document -- PDF / Word / Image ★
📄
Click to attach SOP document
PDF · Word (.docx/.doc) · Image · Excel
📌 21 CFR §11.10 · Document stored securely · Version controlled
Training Attendance Record
📄

Attach PDF / Image

Initiate Stability Study Protocol
ICH Q1A(R2) · WHO TRS 953 · 3 Primary Batches Recommended
📎 Evidence & Raw Data Attachments
Stability Protocol (PDF)
📄

Attach PDF / Image

Stability Data Sheets
📄

Attach PDF / Image

New Content Uniformity Test
USP <905> · Stage 1 (n=10) / Stage 2 (n=30) · 21 CFR 11.10(e)
Content Uniformity — Final Disposition
E-signature · 21 CFR 11.50 / 11.70 / 11.200(a)
Log Product Complaint
21 CFR 211.198 · Schedule M Cl.18 · WHO PV Guidelines
📎 Evidence & Raw Data Attachments
Complaint Letter / Communication
📄

Attach PDF / Image

Investigation Report
📄

Attach PDF / Image

ADR / Regulatory Report
📄

Attach PDF / Image

📋 Master Formula Record (MFR)
21 CFR 211.186 · Schedule M Cl.16.1 · WHO TRS 961 · ICH Q8 · Version-controlled · QP Approved
Product Identification & Batch Parameters
X: I=Injection · C=Capsule · T=Tablet · OS=Oral Suspension
Batch Size & Yield
Manufacturing & Storage Conditions
Create Validation Record
IQ/OQ/PQ · Process · Cleaning · Analytical Method · CSV/GAMP 5
📎 Evidence & Raw Data Attachments
Validation Protocol (PDF)
📄

Attach PDF / Image

Validation Report (PDF) ★
📄

Attach PDF / Image

Certificate of Validation
📄

Attach PDF / Image

Add Regulatory Dossier / Submission
CDSCO · USFDA · EMA · WHO Prequalification · CTD Format · Full Dossier Attachment
Submission Details
CTD Dossier Parts -- Attach All Applicable Modules
CTD Module Content Description Attach Document Attached Files
Module 1 Administrative -- Application forms, product information, labelling, prescribing information
Module 2 Summaries -- Quality Overall Summary (QOS), Non-clinical, Clinical Summary
Module 3 Quality -- Drug substance (API), Drug product, Excipients, Container closure system
Module 4 Non-clinical -- Pharmacology, Pharmacokinetics, Toxicology study reports
Module 5 Clinical -- Clinical study reports, Bioequivalence, Clinical pharmacology
Site Master File Site Master File / GMP Certificate / Manufacturing Licence
Bioequivalence BE Study Report / Comparative Dissolution Data
Deficiency Reply Response to Authority Queries / Deficiency Letter
Approval Docs Approval Letter / Marketing Authorisation / Import Licence
Other Any other supporting documents not covered above
Query / Deficiency Log